- Government policy changes related to climate change.
- Potential negative public perception due to insufficient climate action.
- Climate change impacts on energy prices and production costs.
- Emergence of new technological standards due to climate change.
- Acute and chronic physical risks from climate events.
3D Medicines Inc.
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, 3D Medicines Inc. disclosed greenhouse gas emissions of 412.85 tCO₂e (indirect). By scope: Scope 2: 412.85 tCO₂e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
412.85 tCO₂e (indirect)
2023
Water Usage
2.8K m3
2023
Waste
43.71 tons (hazardous)
2023
Energy Use
723.9K kWh
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 412.85 tCO₂e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 412.85 tCO₂e (indirect) |
| 2022 | 3.7K tCO2e/year |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Total electricity consumption decreased by 36.20% year-on-year.
- All R&D centers meet local emission standards.
- Zero major environmental problems or penalties in 2023.
🌱 ESG Focus Areas
Environmental ManagementEmployee Well-beingCorporate GovernanceR&D InnovationSupply Chain ManagementCommunity Engagement